Literature DB >> 2567203

Myocardial infarct expansion during indomethacin or ibuprofen therapy for symptomatic post infarction pericarditis. Influence of other pharmacologic agents during early remodelling.

B I Jugdutt1, C A Basualdo.   

Abstract

Evidence of acute infarct expansion and the frequency of the acute infarct expansion syndrome (acute infarct dilatation and thinning associated with hypotension and left ventricular failure but no evidence of new necrosis) occurring at two days or more after a first acute Q-wave myocardial infarction were studied using serial two-dimensional echocardiography in 221 consecutive patients (100 anterior, 121 inferior). Patients with symptomatic pericarditis were treated with indomethacin (group 1, n = 73) or ibuprofen (group 2, n = 49) and those without symptomatic pericarditis received neither drug (group 3, n = 99). The overall frequency of the acute infarct expansion syndrome was 13% and 69% of these were among the pericarditis groups. The syndrome was significantly more frequent in group 1 (22%) than group 2 (8%) (P less than 0.05) or group 3 (9%) (P less than 0.025). Serial echocardiograms revealed more expansion with greater percentage increase in the infarct containing segment length in group 1 than group 2 or group 3 (18% versus 9% versus 9%, P less than 0.005). However, the decreases in infarct segment thickness were similar in groups 1 (24%) and 2 (25%) but greater (P less than 0.001) than in group 3 (7%). Despite similar infarct size and infarct thinning in groups 1 and 2, the degree of infarct expansion was greater and the infarct expansion syndrome more frequent in group 1. However, when allowance was made for the potential protective effect of prior use of intravenous nitroglycerin and concomitant use of nifedipine, indomethacin and ibuprofen had similar effects on expansion. Thus, indomethacin or ibuprofen should be used with caution after Q-wave infarction so as to avoid further expansion. The fact that short term use of other drugs might modify infarct remodelling should be considered in studies attempting to assess efficacy of one particular drug.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2567203

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  13 in total

1.  Post-Myocardial Infarction Pericarditis.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-08

2.  Therapeutic drugs during healing after myocardial infarction modify infarct collagens and ventricular distensibility at elevated pressures.

Authors:  Bodh I Jugdutt; Halliday Idikio; Richard R E Uwiera
Journal:  Mol Cell Biochem       Date:  2007-05-09       Impact factor: 3.396

Review 3.  Pleiotropic effects of cardiac drugs on healing post-MI. The good, bad, and ugly.

Authors:  Bodh I Jugdutt
Journal:  Heart Fail Rev       Date:  2008-02-07       Impact factor: 4.214

4.  Time course studies on the initiation of complement activation in acute myocardial infarction induced by coronary artery ligation in rats.

Authors:  Miriyala Sumitra; Panchatcharam Manikandan; Mohammed Nayeem; Bhakthavatsalam Murali Manohar; Beema Lokanadam; Subbiah Vairamuthu; Samu Subramaniam; Rengarajulu Puvanakrishnan
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

5.  [Mechanical complications of acute myocardial infarction].

Authors:  T Brunschwig; F R Eberli; T Herren
Journal:  Z Kardiol       Date:  2004-11

Review 6.  Pericardial disease: diagnosis and management.

Authors:  Masud H Khandaker; Raul E Espinosa; Rick A Nishimura; Lawrence J Sinak; Sharonne N Hayes; Rowlens M Melduni; Jae K Oh
Journal:  Mayo Clin Proc       Date:  2010-06       Impact factor: 7.616

7.  Apoptosis after reperfused myocardial infarction: Role of angiotensin II.

Authors:  Bodh I Jugdutt
Journal:  Exp Clin Cardiol       Date:  2004

8.  Transient release of lipid peroxidation products as a non-invasive marker of successful reperfusion after thrombolysis for myocardial infarction.

Authors:  H Ohlin; C G Gustavsson; E Pantev; B Thorvinger; A K Ohlin
Journal:  Br Heart J       Date:  1995-03

9.  Loss of muscle-specific RING-finger 3 predisposes the heart to cardiac rupture after myocardial infarction.

Authors:  Jens Fielitz; Eva van Rooij; Jeffrey A Spencer; John M Shelton; Shuaib Latif; Roel van der Nagel; Svetlana Bezprozvannaya; Leon de Windt; James A Richardson; Rhonda Bassel-Duby; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-02       Impact factor: 11.205

10.  Enhanced interleukin-1 activity contributes to exercise intolerance in patients with systolic heart failure.

Authors:  Benjamin W Van Tassell; Ross A Arena; Stefano Toldo; Eleonora Mezzaroma; Tania Azam; Ignacio M Seropian; Keyur Shah; Justin Canada; Norbert F Voelkel; Charles A Dinarello; Antonio Abbate
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.